September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence in adult and pediatric extracorporeal membrane oxygenation, or ECMO--an often lifesaving treatment where blood is pumped outside of a patient’s body to a portable heart-lung machine, giving the patient’s own organs a re

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates of systolic, or top number, blood pressure being controlled during an outpatient visit appeared to slightly decrease during winter months, according to a new study presented during the American Heart Association (AHA) Hypertens

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).

September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin signaling inhibitor biologic, for adults with pulmonary arterial hypertension (PAH) (WHO Group 1) at the 

The global interventional cardiology device market is driven by the number of procedures performed across the globe

The global interventional cardiology device market is driven by the number of procedures performed across the globe.

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality. But 10-year conditional survival was similar for biventricular and most single-ventricle CHD patients, and notably better for biventricular CHD patients compared to non-CHD heart transplant recipients. 

September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, “Driving Urgency in LDL Screening,” to increase the rate of diagnostic 

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing cardiovascular digital health innovators to the Emerald City. HRX is a global health and technology conference that convenes clinicians, engineers, product developers, investors, entrepreneurs, regulators, nonprofits, and patient advocacy groups together in an immersive, interactive experience.

September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR.

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, has hired

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now